Know Cancer

or
forgot password

Effects of Leaf Extract of Azadirachta Indica in Palmer Arsenical Keratosis: Randomized, Double Blind, Placebo-controlled Trial


N/A
18 Years
60 Years
Open (Enrolling)
Both
Arsenical Keratosis

Thank you

Trial Information

Effects of Leaf Extract of Azadirachta Indica in Palmer Arsenical Keratosis: Randomized, Double Blind, Placebo-controlled Trial


The objective of this study is to evaluate the effectiveness of topical administration of
the Leaf of Azadirachta indica in the treatment of palmer arsenical keratosis. Fifty
patients of moderate palmer arsenical keratosis patients from an arsenic affected area will
be recruited on the basis of inclusion and exclusion criteria and had been drinking arsenic
contaminated water for more than six months. They will be divided into two groups each will
consist of twenty five members. One group will be provided A. indica plus 6% salicylic
acid ointment to apply on palm overnight daily for 12 weeks. Another group will be provided
6% salicylic acid ointment . Water and nail sample will be collected before starting
recruitment to confirm diagnosis. Then again nail sample will be collected before and after
the study to see the level of arsenic in skin. Effects will be observed after every two
weeks and change will be detected as nil, mild reduction, moderate reduction and fully
cured.


Inclusion Criteria:



- Palmer arsenical keratosis

- Drinking arsenic contaminated water (>50 ppb) for more than six months

- Patient voluntarily agree to participate

Exclusion Criteria:

- Pregnancy

- Lactating mother

- Diabetes mellitus

- Rheumatoid arthritis

- Systemic lupus erythematosus

- Psoriasis

- Bowen's disease

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Outcome Measure:

Changes in palmer arsenical keratosis

Outcome Description:

Size and number of keratotic lesions will be reduced. These will be expressed in score.

Outcome Time Frame:

0 week (baseline), 12 weeks (end)

Safety Issue:

No

Principal Investigator

Mir Misbahuddin, MBBS, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

BSMMU

Authority:

Bangladesh: Ethical Review Committee

Study ID:

BSMMU-003-CT

NCT ID:

NCT01731756

Start Date:

January 2013

Completion Date:

March 2014

Related Keywords:

  • Arsenical Keratosis
  • Palm
  • Arsenic
  • Keratosis
  • Salicylic acid
  • Azadirachta indica
  • Neem
  • Keratosis
  • Keratosis, Actinic
  • Ichthyosis
  • Keratoacanthoma

Name

Location